rs2920297

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005672.5(PSCA):​c.133+231A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.458 in 609,096 control chromosomes in the GnomAD database, including 65,065 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 14944 hom., cov: 31)
Exomes 𝑓: 0.46 ( 50121 hom. )

Consequence

PSCA
NM_005672.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -5.30

Publications

10 publications found
Variant links:
Genes affected
PSCA (HGNC:9500): (prostate stem cell antigen) This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene includes a polymorphism that results in an upstream start codon in some individuals; this polymorphism is thought to be associated with a risk for certain gastric and bladder cancers. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
JRK (HGNC:6199): (Jrk helix-turn-helix protein) This gene encodes a conserved protein that is similar to DNA-binding proteins, such as major centromere autoantigen B (CENPB). Inactivation of the related gene in mice resulted in epileptic seizures. Childhood Absence Epilepsy (CAE) has been mapped to the same chromosomal location (8q24.3) as this gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.502 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PSCANM_005672.5 linkc.133+231A>G intron_variant Intron 2 of 2 ENST00000301258.5 NP_005663.2 O43653D3DWI6
PSCANR_033343.2 linkn.380+231A>G intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PSCAENST00000301258.5 linkc.133+231A>G intron_variant Intron 2 of 2 1 NM_005672.5 ENSP00000301258.4 O43653

Frequencies

GnomAD3 genomes
AF:
0.443
AC:
66953
AN:
151304
Hom.:
14917
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.390
Gnomad AMI
AF:
0.390
Gnomad AMR
AF:
0.511
Gnomad ASJ
AF:
0.517
Gnomad EAS
AF:
0.352
Gnomad SAS
AF:
0.415
Gnomad FIN
AF:
0.510
Gnomad MID
AF:
0.475
Gnomad NFE
AF:
0.454
Gnomad OTH
AF:
0.442
GnomAD4 exome
AF:
0.464
AC:
212230
AN:
457674
Hom.:
50121
Cov.:
4
AF XY:
0.462
AC XY:
111310
AN XY:
240714
show subpopulations
African (AFR)
AF:
0.388
AC:
5013
AN:
12918
American (AMR)
AF:
0.541
AC:
11683
AN:
21578
Ashkenazi Jewish (ASJ)
AF:
0.506
AC:
7114
AN:
14068
East Asian (EAS)
AF:
0.516
AC:
16020
AN:
31034
South Asian (SAS)
AF:
0.449
AC:
21264
AN:
47410
European-Finnish (FIN)
AF:
0.504
AC:
15081
AN:
29922
Middle Eastern (MID)
AF:
0.479
AC:
1224
AN:
2556
European-Non Finnish (NFE)
AF:
0.452
AC:
122832
AN:
271784
Other (OTH)
AF:
0.454
AC:
11999
AN:
26404
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
5651
11302
16954
22605
28256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
694
1388
2082
2776
3470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.443
AC:
67019
AN:
151422
Hom.:
14944
Cov.:
31
AF XY:
0.443
AC XY:
32802
AN XY:
73970
show subpopulations
African (AFR)
AF:
0.390
AC:
16085
AN:
41206
American (AMR)
AF:
0.511
AC:
7794
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.517
AC:
1790
AN:
3460
East Asian (EAS)
AF:
0.352
AC:
1800
AN:
5114
South Asian (SAS)
AF:
0.414
AC:
1985
AN:
4790
European-Finnish (FIN)
AF:
0.510
AC:
5356
AN:
10508
Middle Eastern (MID)
AF:
0.469
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
0.454
AC:
30787
AN:
67806
Other (OTH)
AF:
0.444
AC:
931
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1913
3826
5738
7651
9564
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
622
1244
1866
2488
3110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.453
Hom.:
8204
Bravo
AF:
0.439
Asia WGS
AF:
0.402
AC:
1397
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.40
DANN
Benign
0.22
PhyloP100
-5.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2920297; hg19: chr8-143763083; API